CAS RN: 254973-02-9

AABD-SH (=4-Acetamido-7-mercapto-2,1,3-benzoxadiazole) [for HPLC Labeling]

Product Availability

Choose a grade to view its available package options.

3 package records2 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250630 100mg In stock Inquiry
Batchno.20260425 10mg Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251222 10mg In stock Chongqing Inquiry
  • Product code: ICTA5576
  • Purity/Analytical Methods: >95.0%(HPLC)
GET A QUOTE

254973-02-9 / N-(4-sulfanyl-2,1,3-benzoxadiazol-7-yl)acetamide

Standard CAS: 254973-02-9 Multi CAS: No

Basic Information

CAS
254973-02-9
Multi CAS
No
Molecular Formula
C8H7N3O2S
Molecular Weight
209.230000
Exact Mass
209.025898
SMILES
CC(=O)NC1=CC=C(C2=NON=C12)S
InChI
InChI=1S/C8H7N3O2S/c1-4(12)9-5-2-3-6(14)8-7(5)10-13-11-8/h2-3,14H,1H3,(H,9,12)
InChIKey
FNYDOGDWHMLWTG-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
14
Aromatic heavy atom count
9
Fraction Csp3
0.12
Rotatable bonds
1
H-bond acceptors
5
H-bond donors
2
Molar refractivity
53.36
TPSA
68.02

LogP / Solubility

WLOGP
1.47
MLOGP
1.29
XLogP3
0.5
Consensus LogP
1.09
Log S (ESOL)
-2.47
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.34
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.36
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.95

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
1.5

Get In Touch

Contact Us